DISCLOSURES This activity is jointly provided by Northwest Portland Area Indian Health Board and Cardea
DISCLOSURES COMPLETING THIS ACTIVITY Successful completion of this continuing education activity includes the following: Attending the entire CE activity; Completing the online evaluation; Submitting an online CE request. Your certificate will be sent via email If you have any questions about this CE activity, contact Michelle Daugherty at mdaugherty@cardeaservices.org or (206) 447-9538
DISCLOSURES Faculty: Jonathan Owen, PharmD & Neelam Gazarian, PharmD CME Committee: David Couch; Kathleen Clanon, MD; Johanna Rosenthal, MPH; Pat Blackburn, MPH; Richard Fischer, MD; Sharon Adler, MD CNE Committee: David Stephens, BSN, RN; Erin Edelbrock MPA; Ginny Cassidy-Brinn MSN, ARNP; Carolyn Crisp, MPH
CONFLICT OF INTEREST Richard Fischer, MD is a member of an Organon speaker s bureau. Dr. Fischer does not participate in planning in which he has a conflict of interest, and he ensures that any content or speakers he suggests will be free of commercial bias. None of the other planners or presenters of this CE activity have disclosed any conflict of interest including no relevant financial relationships with any commercial companies pertaining to this CE activity.
Acknowledgement This presentation is funded in part by: The Indian Health Service HIV/AIDS & Hep C Program and The Secretary s Minority AIDS Initiative Fund There is no commercial support for this presentation
Outcomes and Objectives: Conference Objective: At the completion of this activity, the learner will be able to explain the steps that would be necessary to begin to screen for and treat patients with the Hepatitis C Virus (HCV) at their practice sites. By the end of this learning event participants will be able to: Describe tools for management of the care of HCV patients and how to implement them
Starting a HCV Treatment Program-Belcourt Authored and Presented by: LCDR Jonathan Owen, PharmD LT Neelam Gazarian, MS, PharmD Quentin N. Burdick Memorial Health Care Facility Indian Health Service Belcourt, ND 12/14/2017
Agenda Describe use of tools to manage complex care of hepatitis C patients, discuss workload capabilities. Share resources of NICE Project with participants to help manage hepatitis C clinic. http://www.hepatitiscentral.com/wp-content/uploads/2015/04/expenisive-hepatitis-c-medication.jpg http://aph.org.ua/wp-content/uploads/2016/08/bez-nazvanyya-4.png
Who are we?
Prior to HCV Clinic With Insurance (Pvt./Federal) Without Insurance Referred to Medical Specialists Very Few Options $10,000-$15000/referral Rationing Care Distance Lost to follow-up Poor outcomes
Inter-collaborative Approach Primary Care Provider Public Health Pharmacist Patient Behavioral Health Laboratory Services Benefits Coordinator
Identifying Patients with Hepatitis C icare VGEN 168 patients 25% screening rate 155 patients
EHR Documentation Referral Initial Visit Comprehensive visit Treatment End of Treatment SVR Consult from PCP PHQ-9 AUDIT-C Project ECHO Counseling Labs Patient is cured! Walk in Education Start Medication Authorization Labs Counsel about re-infection and prevention Labs Immunizations Immunizations
Consult Template
EHR Note Templates
EHR Note Templates
Hepatitis C Labs Order Menu
Hepatitis C Labs Order Set
Patient Management Tools icare Panel Consults Excel Panel List NICE Hep C Tool
Hepatitis C Patient Panel List Managing Patients Excel document for patient management Created by Jessica Leston, Brigg Reilley, and David Stephens Automatically calculates APRI, FIB 4 scores Excellent for helping to prioritize patients based on liver function and viral load
Hepatitis C Patient Panel List Managing Patients New panel created by Nelly to help manage patients referred to the clinic Spin-off of previous panel, automatically calculates APRI, FIB 4 scores Organized by stage in the treatment processes Reminders for labs while in treatment, immunizations, notes
Managing Patients Snapshot of stage in treatment process drop down menus (these can be adjusted)
Patient Panel
Individual Patient Data
Appointment Calendar
Navigating Insurance/Prior Authorizations Comprehensive Visit Clinic Notes Project ECHO Recommended regimen Lab Values Chem 14, CBC, anemia panel, Vit D, AFT, HIV, Hep A & B, pregnancy Viral load and genotype Fibrosis Score: APRI, FIB4, Fibrotest Abstinence requirements Urine drug screens and/or clinical notes Compliance
Patient Assistance Program Gilead s Support Path Harvoni, Epclusa iassist: https://www.assistrx.com/iassist/ AbbVie Patient Assistance Foundation Mavyret
Patient Assistance Programs Tribal ID card Income documents Max income allowed differs by program Proof of no insurance American Indians/Alaska Natives (AI/AN): Indian Health Coverage Exemption American Indians and Alaska Natives (AI/ANs) and other people eligible for services through the Indian Health Service, tribal programs, or urban Indian programs (like the spouse or child of an eligible Indian) don't have to pay the fee for not having health coverage. This is called having an Indian health coverage exemption.
Time Investment and Workload (Minutes) 30 Initial Visit 30 ECHO 30 Prior Authorization 60 Treatment 30 Counseling
Current Status Pending 8 3 Project Echo Medication Approval Pending 3 8 Treatment ETR 4 2 SVR cure 8 11 14 22 26 28
Patients Enrolled in Clinic AGE DISTRIBUTION Baby Boomers 36% Non-Baby Boomers 64%
43.0% 41.0% HCV Screening Rate 42.1% 39.0% 37.0% 36.2% 35.0% 33.0% 31.0% 29.0% 27.0% 27.3% 25.3% 25.0% 5/31/2017 6/30/2017 7/31/2017 8/31/2017 9/30/2017 10/31/2017 11/30/2017
HCV Screening Rate
Cost Analysis: Cumulative $1,200,000 $1,000,000 $203,112 $800,000 $363,240 $600,000 $1,123,776 IHS Source Medicaid/Exp $400,000 PAP $200,000 $557,424 $62,421 $172,467 $110,046 $0 Total Retail Value Cost of Meds to Clinic POS Revenue Total Return
Next Steps Leading efforts in the Great Plains, Bemidji and Billings Areas Sharing experiences and resources with other service units
Next Steps Behavioral Health Emergency Room Dental POC Testing (>14 years) Public Health Clinic Pharmacy
Success Story ND Medicaid and Expansion Drop minimum fibrosure score requirements 12-months abstinence requirements remains No NS5A resistance test required unless prescribing Zepatier
Medicaid Letter Balancing Act STATE CLINIC
Hepatitis Listserv Share info via text HCV to 97779 Create a NICE Project Listserv to continuously improve and grow resources Create a MAX.gov to share resources
Patient s Story First patient enrolled in HCV clinic summer of 2017, achieved SVR mid-november I have been waiting for this for so long. I know I have made some mistakes in the past, but I had started to turn my life around. I am very thankful to them for not being judgmental and for treating me with respect. I am finally able to start a family. God bless you! - First patient to attain SVR in HCV clinic
Recorded Webinars http://www.npaihb.org/hcv/#clinical-resources How to create an icare panel How to create a quick order menu for required labs How to use the NICE patient management tool Hepatitis C clinic workflow Medicaid Letter, appointment cards
Special Thanks Jessica Leston, HCV/HIV/STI Clinical Programs Director for the Northwest Portland Area Indian Health Board Brigg Reilley, National HIV/AIDS Program David Stephens, BSN, RN, Case Manager for the Northwest Portland Area Indian Health Board.
Questions
Thank you Contact Info: Neelam.Gazarian@ihs.gov Jonathan.Owen@ihs.gov 701-477-6111 Ext 8426